Koyfin Home > Directory > Health Care > Gilead Sciences Inc > Net Change in Cash

Gilead Sciences Inc Net Change in Cash Chart (GILD)

Gilead Sciences Inc annual/quarterly Net Change in Cash from 2010 to 2020.
  • Gilead Sciences Inc Net Change in Cash for the quarter ending September 09, 2020 was $6,140m a 64.87% increase of 3,983m year over year
  • Gilead Sciences Inc Net Change in Cash for the last 12 months ending September 09, 2020 was $3,412m a 284.91% increase of 9,721m year over year
  • Gilead Sciences Inc Annual Net Change in Cash for 2019 was $-6,309m a 264.08% decrease of -16,661m from 2018
  • Gilead Sciences Inc Annual Net Change in Cash for 2018 was $10,352m a 106.19% increase of 10,993m from 2017
  • Gilead Sciences Inc Annual Net Change in Cash for 2017 was $-641m a -621.06% increase of 3,981m from 2016
Other Cash Flow Metrics:
  • Gilead Sciences Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $2,212m a -24.46% decrease of -541m year over year
  • Gilead Sciences Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $1,592m a -123.19% decrease of -1,962m year over year
  • Gilead Sciences Inc Total Revenue for the quarter ending December 12, 2018 was $5,795m a 12.20% increase of 707m year over year
View Chart On Koyfin

Quarterly GILD Net Change in Cash Data

09/2020$6,140m
06/2020$-3,305m
03/2020$-1,580m
12/2019$2,157m
09/2019$-1,766m
06/2019$-5,687m
03/2019$-1,013m
12/2018$3,371m
09/2018$1,335m
06/2018$5,591m

Annual GILD Net Change in Cash Data

2019$-6,309m
2018$10,352m
2017$-641m
2016$-4,622m
2015$2,824m
2014$7,914m
2013$309m
2012$-8,080m
2011$8,976m
2010$-365m